Wedelolactone inhibits ferroptosis and alleviates hyperoxia-induced acute lung injury via the Nrf2/HO-1 signaling pathway
Toxicological Sciences · 01.11.2024 · 202 (1) · 25-35
DOI: 10.1093/toxsci/kfae099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 07.08.2024. Verfasst von Kang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Acute Lung Injury, Hyperoxia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Department of Science and Technology, Guizhou Provincial Health Commission.
Abstract (Originalsprache)
Hyperoxia-induced acute lung injury (HALI) is a complication of oxygen therapy. Ferroptosis is a vital factor in HALI. This paper was anticipated to investigate the underlying mechanism of wedelolactone (WED) on ferroptosis in HALI. The current study used hyperoxia to injure two models, one HALI mouse model and one MLE-12 cell injury model. We found that WED treatment attenuated HALI by decreasing the lung injury score and lung wet/dry (W/D) weight ratio and alleviating pathomorphological changes. Then, the inflammatory reaction and apoptosis in HALI mice and hyperoxia-mediated MLE-12 cells were inhibited by WED treatment. Moreover, WED alleviated ferroptosis with less iron accumulation and reversed expression alterations of ferroptosis markers, including MDA, GSH, GPX4, SLC7A11, FTH1, and TFR1 in hyperoxia-induced MLE-12 cells in vitro and in vivo. Nrf2-KO mice and Nrf2 inhibitor (ML385) decreased WED’s ability to protect against apoptosis, inflammatory response, and ferroptosis in hyperoxia-induced MLE-12 cells. Collectively, our data highlighted the alleviatory role of WED in HALI by activating the Nrf2/HO-1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
- Department of Pediatric, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
- Department of Critical Care Medicine, Zunyi Hospital of Traditional Chinese Medicine, Zunyi, Guizhou 563000, P.R. China.
ORCID-Profile: Song Qin
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Department of Science and Technology
- Guizhou Provincial Health Commission
Zitieren
APA
Li, K., Wang, X. Q., Liao, Z. L., Liu, J. Y., Feng, B. H., Ren, Y. C., Dai, N. N., Yu, K., Yu, H., Chen, H. J., Mei, H., & Qin, S. (2024). Wedelolactone inhibits ferroptosis and alleviates hyperoxia-induced acute lung injury via the Nrf2/HO-1 signaling pathway. Toxicological Sciences, 202(1), 25-35. https://doi.org/10.1093/toxsci/kfae099
Vancouver
Li K, Wang XQ, Liao ZL, Liu JY, Feng BH, Ren YC, et al. Wedelolactone inhibits ferroptosis and alleviates hyperoxia-induced acute lung injury via the Nrf2/HO-1 signaling pathway. Toxicological Sciences. 2024;202(1):25-35. doi:10.1093/toxsci/kfae099
BibTeX
@article{Li2024,
author = {Li, Kang and Wang, Xiao-Qin and Liao, Zhen-Liang and Liu, Jun-Ya and Feng, Bang-Hai and Ren, Ying-Cong and Dai, Ni-Nan and Yu, Kun and Yu, Hong and Chen, Hua-Jun and Mei, Hong and Qin, Song},
title = {Wedelolactone inhibits ferroptosis and alleviates hyperoxia-induced acute lung injury via the Nrf2/HO-1 signaling pathway},
journal = {Toxicological Sciences},
year = {2024},
volume = {202},
number = {1},
pages = {25--35},
doi = {10.1093/toxsci/kfae099}
}
EUVIMED